Merrimack Pharmaceuticals
MACK
#7838
Rank
A$0.34 B
Marketcap
$23.26
Share price
0.00%
Change (1 day)
19.14%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -A$3.44 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$3.35 Million a decrease over its 2022 earnings that were of -A$3.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$3.44 Million2.56%
2023 -A$3.35 Million0.09%
2022 -A$3.35 Million-16.9%
2021 -A$4.03 Million-49.89%
2020 -A$8.03 Million-75.39%
2019 -A$32.62 Million-68.58%
2018 -A$0.11 Billion-19.4%
2017 -A$0.13 Billion-36.46%
2016 -A$0.21 Billion2.54%
2015 -A$0.2 Billion96.78%
2014 -A$0.11 Billion-45.44%
2013 -A$0.19 Billion
2010 -A$71.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.39 B-328,025.63%๐Ÿ‡ซ๐Ÿ‡ท France
-A$44.66 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.33 Billion 9,125.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.34 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$33.37 Million 860.69%๐Ÿ‡บ๐Ÿ‡ธ USA